TREVOR CABLE: Open Payments
NPI 1376146241 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 36 payments from 8 companies in 2025. Trend: 2023 $188 · 2024 $335 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $193 |
| Janssen Biotech, Inc. | 10 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $159 |
| Ipsen Biopharmaceuticals, Inc | 4 | $91 |
| Ardelyx, Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $15 |
Products named: GEMTESA, TREMFYA, ENTYVIO, IQIRVO, IBSRELA, DUPIXENT, VEGZELMA, EOHILIA.
Industry payments across VA — which companies pay providers there.
